Cancer cells seldom start off stealthy ... the team turned to an FDA-approved drug used to treat Gaucher disease—a genetic disorder characterized by an impaired ability to break down lipids.
Diseases like Gaucher disease, Tay-Sachs disease, Niemann-Pick disease, and Pompe disease result from waste buildup in cells, leading to serious health issues. Dysfunctions of the lysosomal ...
Dr. Uzman showed that analysis of fat-like lipid, kerasin, as performed over the previous 40 years, was not enough to explain the peculiar Gaucher cells, sign of the disease. It is also necessary ...
Diseases like Gaucher disease, Tay-Sachs disease, Niemann-Pick disease, and Pompe disease result from waste buildup in cells, leading to serious health issues. Dysfunctions of the lysosomal ...
Diseases like Gaucher disease, Tay-Sachs disease, Niemann-Pick disease, and Pompe disease result from waste buildup in cells, leading to serious health issues. Dysfunctions of the lysosomal ...
Gaucher's disease is the most prevalent among ... “This was a unique opportunity to take advantage of their plant cell technology platform with this lead drug to perhaps provide a more cost ...
Genzyme anticipates supply constraints of Cerezyme (imiglucerase), a treatment for Gaucher disease, and Fabrazyme (agalsidase beta), used to treat Fabry disease, while the facility shuts down for ...